[go: up one dir, main page]

WO2008030771A8 - Composés d'alkylidène cycliques en tant que modulateurs sélectifs des récepteurs des œstrogènes - Google Patents

Composés d'alkylidène cycliques en tant que modulateurs sélectifs des récepteurs des œstrogènes

Info

Publication number
WO2008030771A8
WO2008030771A8 PCT/US2007/077356 US2007077356W WO2008030771A8 WO 2008030771 A8 WO2008030771 A8 WO 2008030771A8 US 2007077356 W US2007077356 W US 2007077356W WO 2008030771 A8 WO2008030771 A8 WO 2008030771A8
Authority
WO
WIPO (PCT)
Prior art keywords
estrogen receptor
selective estrogen
receptor modulators
cyclic alkylidene
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/077356
Other languages
English (en)
Other versions
WO2008030771A1 (fr
Inventor
William John Zuercher
Dennis Heyer
Aaron Bayne Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of WO2008030771A1 publication Critical patent/WO2008030771A1/fr
Publication of WO2008030771A8 publication Critical patent/WO2008030771A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne de nouveaux composés ayant diverses utilisations thérapeutiques, plus particulièrement de nouveaux composés d'alkylidène cycliques substitués qui sont particulièrement utiles pour la modulation sélective des récepteurs des œstrogènes.
PCT/US2007/077356 2006-09-08 2007-08-31 Composés d'alkylidène cycliques en tant que modulateurs sélectifs des récepteurs des œstrogènes Ceased WO2008030771A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82492006P 2006-09-08 2006-09-08
US60/824,920 2006-09-08

Publications (2)

Publication Number Publication Date
WO2008030771A1 WO2008030771A1 (fr) 2008-03-13
WO2008030771A8 true WO2008030771A8 (fr) 2008-05-15

Family

ID=38983569

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/077356 Ceased WO2008030771A1 (fr) 2006-09-08 2007-08-31 Composés d'alkylidène cycliques en tant que modulateurs sélectifs des récepteurs des œstrogènes

Country Status (1)

Country Link
WO (1) WO2008030771A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102786394B (zh) * 2012-07-30 2017-03-01 中国医学科学院医药生物技术研究所 取代双芳基亚甲基环烷基衍生物及其制备方法和应用
EP3266771B1 (fr) 2016-06-10 2019-02-20 Paris Sciences Et Lettres - Quartier Latin Synthèse de cyclofen-oh en cage photoactivable et ses dérivés

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5013593B2 (ja) * 2003-07-28 2012-08-29 スミスクライン ビーチャム コーポレーション 化合物

Also Published As

Publication number Publication date
WO2008030771A1 (fr) 2008-03-13

Similar Documents

Publication Publication Date Title
WO2006065480A3 (fr) Tetrahydrocarbazoles en tant qu'agents actifs permettant d'inhiber la production de vegf par regulation de la traduction
WO2008009415A3 (fr) Dérivés hétéroaryliques substitués
WO2009020234A3 (fr) Composes d'amine cyclique
WO2010015657A3 (fr) Nouveaux alcoxypyrazoles
WO2010074394A3 (fr) Compositions de résine de polypropylène présentant une tension élevée à l'état fondu et procédé de préparation de celles-ci
WO2007062148A3 (fr) Composes chimiques
WO2007062190A3 (fr) Composes chimiques
WO2007062151A3 (fr) Composes chimiques
WO2008116147A3 (fr) Compositions structurées comprenant une argile
MX2009007336A (es) Indazoles substituidos con 5-furopiridinona.
WO2007062145A3 (fr) Composes chimiques
WO2007062067A3 (fr) Composes chimiques
DK2094684T3 (da) 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-on som CB1-receptor modulatorer
AU2008334489A1 (en) Cannabinoid receptor modulators
WO2010057088A3 (fr) Modulateurs de pyrrolidinyle de récepteurs nicotiniques d'acétylcholine
WO2006002185A8 (fr) Composes chimiques
WO2009154739A3 (fr) Modulateurs du récepteur smoothened
WO2010039885A3 (fr) Formes cristallines du dexlansoprazole
WO2006127871A3 (fr) Modulateurs selectifs du recepteur d'oestrogene
WO2009124733A8 (fr) Dérivés de sulfonamide substitués
WO2008030771A8 (fr) Composés d'alkylidène cycliques en tant que modulateurs sélectifs des récepteurs des œstrogènes
WO2006075139A3 (fr) Procede nouveau
WO2009152474A3 (fr) Procédé de préparation de dérivés de (3s)-3-amino-n-cyclopropyl-2-hydroxyalcanamide
WO2009003732A3 (fr) Peptides dotés d'une haute affinité pour le récepteur de la prolactine
WO2009054483A1 (fr) Medicament contenant de la salusine-β

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07841700

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07841700

Country of ref document: EP

Kind code of ref document: A1